At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Oral Antibiotic and Oral Rinse +1 moredrug
Likely dose
Oral Antibiotic and Oral Rinse 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Peripheral Blood Dendritic Cells and Periodontitis
In Brief
A clinical study evaluating Oral Antibiotic and Oral Rinse and Standard Treatment for Chronic Periodontitis. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The investigators hypothesize that blood dendritic cells harbor pathogens from the oral cavity in chronic periodontitis and disseminate these pathogens to atherosclerotic plaques.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Periodontitis
CountriesUnited States
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedApr 2012
Primary CompletionSep 2014
TodayJul 2026
First PostedApr 2, 2012
Enrollment StartMar 1, 2012
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 14.3 years ago
Interventions
Oral Antibiotic and Oral Rinsedrug
PO Amoxicillin in 500 mg / Metronidazole 250 mg of each TID for 8 days plus 2 ounces of 0.12% chlorhexidine mouthrinse used BID
Standard Treatmentprocedure
Full mouth scaling and root planing using hand instrumentation (curettes) and ultrasonic scalers